CD40LG and COVID-19: The detection of SARS-CoV-2 IgM in patients anamnestically screened as asymptomatic since the first detection of a COVID-19 case in Italy does not allow to exclude the occurrence of a symptomatic infection before that period, especially if no NPS detected viral RNA at the time of the first positive serology.